Epithelial TNF receptor signaling promotes mucosal repair in inflammatory bowel disease

Journal of Immunology

Volumn 199, Issue 5, 2017, Pages 1886-1897

  Bradford, Emily M ^a,b   Ryu, Stacy H ^a   Singh, Ajay Pal ^a   Lee, Goo ^a   Goretsky, Tatiana ^a,b   Sinh, Preetika ^a   Williams, David B ^a   Cloud, Amber L ^b   Gounaris, Elias ^a   Patel, Vihang ^b   Lamping, Olivia F ^b   Lynch, Evan B ^b   Moyer, Mary Pat ^c   De Plaen, Isabelle G ^a   Shealy, David J ^d   Yang, Guang Yu ^a   Barrett, Terrence A ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c INCELL Corporation ^*  (United States)

^d JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DEXTRAN SULFATE; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; WNT PROTEIN;

ADULT STEM CELL; ANIMAL; C57BL MOUSE; CELL LINE; COLITIS; EPITHELIUM CELL; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; INTESTINE MUCOSA; KNOCKOUT MOUSE; METABOLISM; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION; WOUND HEALING;

ADULT STEM CELLS; ANIMALS; ANTIBODIES, MONOCLONAL; BETA CATENIN; CELL LINE; COLITIS; DEXTRAN SULFATE; EPITHELIAL CELLS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; WNT PROTEINS; WOUND HEALING;

EID: 85026873038     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1601066     Document Type: Article

References (41)

1. Bradley, J. R. 2008. TNF-mediated inflammatory disease. J. Pathol. 214: 149-160.
2. Fujino, S., A. Andoh, S. Bamba, A. Ogawa, K. Hata, Y. Araki, T. Bamba, and Y. Fujiyama. 2003. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 52: 65-70.
3. Fuss, I. J., M. Neurath, M. Boirivant, J. S. Klein, C. de la Motte, S. A. Strong, C. Fiocchi, and W. Strober. 1996. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5. J. Immunol. 157: 1261-1270.
4. Neurath, M. F. 2014. Cytokines in inflammatory bowel disease. Nat. Rev. Immunol. 14: 329-342.
5. Rogler, G., and T. Andus. 1998. Cytokines in inflammatory bowel disease. World J. Surg. 22: 382-389.
6. Sandborn, W. J., S. B. Hanauer, S. Katz, M. Safdi, D. G. Wolf, R. D. Baerg, W. J. Tremaine, T. Johnson, N. N. Diehl, and A. R. Zinsmeister. 2001. Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial. Gastroenterology 121: 1088-1094.
7. Waetzig, G. H., P. Rosenstiel, A. Arlt, A. Till, K. Bräutigam, H. Schäfer, S. Rose-John, D. Seegert, and S. Schreiber. 2005. Soluble tumor necrosis factor (TNF) receptor-1 induces apoptosis via reverse TNF signaling and autocrine transforming growth factor-beta1. FASEB J. 19: 91-93.
8. Marchal Bressenot, A., and L. Peyrin-Biroulet. 2016. Letter: histological assessment of disease activity in ulcerative colitis-the problem of score evaluation and validation; authors' reply. Aliment. Pharmacol. Ther. 43: 439.
9. Topol, L., X. Jiang, H. Choi, L. Garrett-Beal, P. J. Carolan, and Y. Yang. 2003. Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J. Cell Biol. 162: 899-908.
10. Pinto, D., A. Gregorieff, H. Begthel, and H. Clevers. 2003. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev. 17: 1709-1713.
11. Sato, T., R. G. Vries, H. J. Snippert, M. van de Wetering, N. Barker, D. E. Stange, J. H. van Es, A. Abo, P. Kujala, P. J. Peters, and H. Clevers. 2009. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459: 262-265.
12. Lee, G., T. Goretsky, E. Managlia, R. Dirisina, A. P. Singh, J. B. Brown, R. May, G. Y. Yang, J. W. Ragheb, B. M. Evers, et al. 2010. Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis. Gastroenterology 139: 869-881, 881.e1-9.
13. He, X. C., T. Yin, J. C. Grindley, Q. Tian, T. Sato, W. A. Tao, R. Dirisina, K. S. Porter-Westpfahl, M. Hembree, T. Johnson, et al. 2007. PTEN-deficient intestinal stem cells initiate intestinal polyposis. Nat. Genet. 39: 189-198.
14. He, X. C., J. Zhang, W. G. Tong, O. Tawfik, J. Ross, D. H. Scoville, Q. Tian, X. Zeng, X. He, L. M. Wiedemann, et al. 2004. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat. Genet. 36: 1117-1121.
15. Barker, N., R. A. Ridgway, J. H. van Es, M. van de Wetering, H. Begthel, M. van den Born, E. Danenberg, A. R. Clarke, O. J. Sansom, and H. Clevers. 2009. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457: 608-611.
16. Miyoshi, H., and T. S. Stappenbeck. 2013. In vitro expansion and genetic modification of gastrointestinal stem cells in spheroid culture. Nat. Protoc. 8: 2471-2482.
17. Qiu, W., Y. Hu, T. E. Andersen, A. Jafari, N. Li, W. Chen, and M. Kassem. 2010. Tumor necrosis factor receptor superfamily member 19 (TNFRSF19) regulates differentiation fate of human mesenchymal (stromal) stem cells through canonical Wnt signaling and C/EBP. J. Biol. Chem. 285: 14438-14449.
18. Fevr, T., S. Robine, D. Louvard, and J. Huelsken. 2007. Wnt/beta-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells. Mol. Cell. Biol. 27: 7551-7559.
19. van der Flier, L. G., M. E. van Gijn, P. Hatzis, P. Kujala, A. Haegebarth, D. E. Stange, H. Begthel, M. van den Born, V. Guryev, I. Oving, et al. 2009. Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell 136: 903-912.
20. Flavin, P., A. Redmond, J. McBryan, S. Cocchiglia, P. Tibbitts, P. Fahy-Browne, E. Kay, A. Treumann, K. Perrem, M. McIlroy, et al. 2011. RuvBl2 cooperates with Ets2 to transcriptionally regulate hTERT in colon cancer. FEBS Lett. 585: 2537-2544.
21. Powell, A. E., Y. Wang, Y. Li, E. J. Poulin, A. L. Means, M. K. Washington, J. N. Higginbotham, A. Juchheim, N. Prasad, S. E. Levy, et al. 2012. The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor. Cell 149: 146-158.
22. Clayburgh, D. R., T. A. Barrett, Y. Tang, J. B. Meddings, L. J. Van Eldik, D. M. Watterson, L. L. Clarke, R. J. Mrsny, and J. R. Turner. 2005. Epithelial myosin light chain kinase-dependent barrier dysfunction mediates T cell activation-induced diarrhea in vivo. J. Clin. Invest. 115: 2702-2715.
23. Tang, Y., D. R. Clayburgh, N. Mittal, T. Goretsky, R. Dirisina, Z. Zhang, M. Kron, D. Ivancic, R. B. Katzman, G. Grimm, et al. 2010. Epithelial NFkappaB enhances transmucosal fluid movement by altering tight junction protein composition after T cell activation. Am. J. Pathol. 176: 158-167.
24. Miura, N., M. Yamamoto, M. Fukutake, N. Ohtake, S. Iizuka, A. Ishige, H. Sasaki, K. Fukuda, T. Yamamoto, and S. Hayakawa. 2005. Anti-CD3 induces bi-phasic apoptosis in murine intestinal epithelial cells: possible involvement of the Fas/Fas ligand system in different T cell compartments. Int. Immunol. 17: 513-522.
25. Goretsky, T., R. Dirisina, P. Sinh, N. Mittal, E. Managlia, D. B. Williams, D. Posca, H. Ryu, R. B. Katzman, and T. A. Barrett. 2012. p53 mediates TNFinduced epithelial cell apoptosis in IBD. Am. J. Pathol. 181: 1306-1315.
26. Church, D. N., and D. C. Talbot. 2012. Survivin in solid tumors: rationale for development of inhibitors. Curr. Oncol. Rep. 14: 120-128.
27. Cohran, V., E. Managlia, E. M. Bradford, T. Goretsky, T. Li, R. B. Katzman, P. Cheresh, J. B. Brown, J. Hawkins, S. X. Liu, et al. 2016. Epithelial PIK3R1 (p85) and TP53 regulate survivin expression during adaptation to ileocecal resection. Am. J. Pathol. 186: 1837-1846.
28. Raj, D., T. Liu, G. Samadashwily, F. Li, and D. Grossman. 2008. Survivin repression by p53, Rb and E2F2 in normal human melanocytes. Carcinogenesis 29: 194-201.
29. Martini, E., E. Schneider, C. Neufert, M. F. Neurath, and C. Becker. 2016. Survivin is a guardian of the intestinal stem cell niche and its expression is regulated by TGF-b. Cell Cycle 15: 2875-2881.
30. Martini, E., N. Wittkopf, C. Gunther, M. Leppkes, H. Okada, A. J. Watson, E. Podstawa, I. Backert, K. Amann, M. F. Neurath, and C. Becker. 2016. Loss of survivin in intestinal epithelial progenitor cells leads to mitotic catastrophe and breakdown of gut immune homeostasis. Cell Reports 14: 1062-1073.
31. Maretto, S., M. Cordenonsi, S. Dupont, P. Braghetta, V. Broccoli, A. B. Hassan, D. Volpin, G. M. Bressan, and S. Piccolo. 2003. Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors. Proc. Natl. Acad. Sci. USA 100: 3299-3304.
32. Koch, S., P. Nava, C. Addis, W. Kim, T. L. Denning, L. Li, C. A. Parkos, and A. Nusrat. 2011. The Wnt antagonist Dkk1 regulates intestinal epithelial homeostasis and wound repair. Gastroenterology 141: 259-268, 268.e1-8.
33. Nava, P., S. Koch, M. G. Laukoetter, W. Y. Lee, K. Kolegraff, C. T. Capaldo, N. Beeman, C. Addis, K. Gerner-Smidt, I. Neumaier, et al. 2010. Interferongamma regulates intestinal epithelial homeostasis through converging betacatenin signaling pathways. Immunity 32: 392-402.
34. Miyoshi, H., R. Ajima, C. T. Luo, T. P. Yamaguchi, and T. S. Stappenbeck. 2012. Wnt5a potentiates TGF-b signaling to promote colonic crypt regeneration after tissue injury. Science 338: 108-113.
35. Barrett, T. A. 2012. Developmental biology. Intestinal wound healing requires a Wnt balancing act. Science 338: 51-52.
36. Merger, M., J. L. Viney, R. Borojevic, D. Steele-Norwood, P. Zhou, D. A. Clark, R. Riddell, R. Maric, E. R. Podack, and K. Croitoru. 2002. Defining the roles of perforin, Fas/FasL, and tumour necrosis factor alpha in T cell induced mucosal damage in the mouse intestine. Gut 51: 155-163.
37. Zganiacz, A., M. Santosuosso, J. Wang, T. Yang, L. Chen, M. Anzulovic, S. Alexander, B. Gicquel, Y. Wan, J. Bramson, et al. 2004. TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. J. Clin. Invest. 113: 401-413.
38. Leppkes, M., M. Roulis, M. F. Neurath, G. Kollias, and C. Becker. 2014. Pleiotropic functions of TNF-a in the regulation of the intestinal epithelial response to inflammation. Int. Immunol. 26: 509-515.
39. Atreya, R., M. Zimmer, B. Bartsch, M. J. Waldner, I. Atreya, H. Neumann, K. Hildner, A. Hoffman, R. Kiesslich, A. D. Rink, et al. 2011. Antibodies against tumor necrosis factor (TNF) induce T-cell apoptosis in patients with inflammatory bowel diseases via TNF receptor 2 and intestinal CD14+ macrophages. Gastroenterology 141: 2026-2038.
40. Schwitalla, S., A. A. Fingerle, P. Cammareri, T. Nebelsiek, S. I. Göktuna, P. K. Ziegler, O. Canli, J. Heijmans, D. J. Huels, G. Moreaux, et al. 2013. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-celllike properties. Cell 152: 25-38.
41. Beutler, B., and G. E. Grau. 1993. Tumor necrosis factor in the pathogenesis of infectious diseases. Crit. Care Med. 21 (10 Suppl): S423-S435.